Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Hologic Inc (NQ: HOLX )

78.97 +0.25 (+0.32%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Hologic Inc

< Previous 1 2 3 4 5 6 Next >
Looking Into Hologic's Recent Short Interest
Via Benzinga
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday. 
Via Benzinga
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints
FDA and Hologic advise health providers to return all unused BioZorb Markers due to adverse events, including pain and infection. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments
Hologic Inc. is acquiring Gynesonics for $350 million, adding the Sonata System to its fibroid treatment lineup. The acquisition aims to boost Hologic's women's health offerings and expand minimally... 
Via Benzinga
Assessing Hologic: Insights From 10 Financial Analysts
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,600 Today
Via Benzinga
Critical Insights From Hologic Analyst Ratings: What You Need To Know
Via Benzinga
Here's How Much You Would Have Made Owning Hologic Stock In The Last 20 Years
Via Benzinga
Peering Into Hologic's Recent Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Hologic Stock In The Last 10 Years
Via Benzinga
Analyst Scoreboard: 8 Ratings For Hologic
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,200 Today
Via Benzinga
GE Aerospace To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Hologic Analysts Boost Their Forecasts After Q3 Results
Via Benzinga
The Analyst Verdict: Hologic In The Eyes Of 8 Experts
Via Benzinga
$1000 Invested In Hologic 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Tech Stocks Drop Ahead Of Key Earnings; Nvidia Falls, CrowdStrike Hits 8-Month Low: What's Driving Markets Tuesday?
Investor sentiment took a hit on Tuesday as caution prevailed ahead of significant market events, including key tech earnings reports and the Federal Open Market Committee meeting. 
Via Benzinga
HOLX Stock Earnings: Hologic Beats EPS, Beats Revenue for Q3 2024
HOLX stock results show that Hologic beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
Here's How Much $100 Invested In Hologic 20 Years Ago Would Be Worth Today
Via Benzinga
Peering Into Hologic's Recent Short Interest
Via Benzinga
Analyst Scoreboard: 7 Ratings For Hologic
Via Benzinga
Wall Street Rises Ahead Of Big Tech Earnings, Fed Meeting; Tesla Rebounds, Oil Prices Drop To 7-Week Lows: What's Driving Markets Monday?
Wall Street opened higher at the start of a data-heavy week, with traders adopting an optimistic tone ahead of crucial earnings reports and economic events. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Attorney Moze Cowper Wins Oral Argument Against Hologic Inc. in BioZorb Litigation
Attorney Moze Cowper Wins Oral Argument Against Hologic Inc. in BioZorb Litigation 
Via News Direct
Topics Lawsuit
Exposures Financial Legal
Women's Health-Focused Hologic Has Significant Capacity For Expansion Via M&A, Bullish Analyst Says
Stephens initiated coverage on Hologic, highlighting its strong position in women's health and molecular diagnostics. Known for robust revenue growth and attractive profit margins, Hologic is set for... 
Via Benzinga
Deep Dive Into Hologic Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
The Analyst Landscape: 4 Takes On Hologic
Via Benzinga
3 Online Sports Betting Stocks That Look Like Likely Winners
After billionaire Carl Icahn invested in Caesars, retail investors should also buy sports betting stocks. Here are three top names. 
Via InvestorPlace
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
HOLX Stock Earnings: Hologic Beats EPS, Beats Revenue for Q2 2024
HOLX stock results show that Hologic beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Based on good technical signals, HOLOGIC INC is potentially setting up for a breakout.
HOLOGIC INC is showing promising signs of setting up for a breakout. 
Via Chartmill
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.